Results 41 to 50 of about 438,994 (167)

Influenza viruses – antiviral therapy and resistance

open access: yesGMS Infectious Diseases, 2017
Influenza is a serious and frequently underestimated, but vaccine preventable disease. The adamantane derivates rimantadine and amantadine and the neuraminidase inhibitors zanamivir and oseltamivir are the only antiviral drugs currently approved in ...
Duwe, Susanne
doaj   +1 more source

2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission. [PDF]

open access: yes, 2020
With the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in coronavirus disease 2019 (COVID-19), corporate entities, federal, state, county, and city governments, universities, school districts, places of worship,
Coil, David A   +5 more
core   +2 more sources

World Flu Day 2024 with One Health Approach in Iran

open access: yesJournal of Medical Microbiology and Infectious Diseases
Introduction: The global impact and significance of influenza are profound, from the 1918 Spanish flu pandemic to recent seasonal and avian influenza outbreaks.
Parvaneh Mehrbod1*, Behrokh Farahmand1
doaj   +1 more source

Epidemiology of parainfluenza virus type 3 in England and Wales over a ten-year period [PDF]

open access: yes, 1989
We have analysed data on respiratory syneytial (RS) and parainfiuenza type 3 (PF3) viruses reported to the Communicable Disease Surveillance Centre. London, over the period 1978–87.
Easton, A. J. (Andrew J.), Eglin, R. P.
core   +1 more source

Comparison of Vero and MDCK cell lines transfected with human siat7e gene for conversion to suspension culture

open access: yesVaccine Research, 2015
Introduction: Inactivated influenza vaccines are traditionally produced in chicken embryonated eggs but its limitations in producing the required doses in pandemic outbreaks quickly enough has made searching for alternative modes of production necessary.
P Mehrbod   +4 more
doaj  

Association of infection-induced antibody levels with risk of subsequent SARS–COV-2 reinfection among healthcare professionals, Rhode Island, 1 March 2020–17 February 2021

open access: yesMicrobiology Spectrum
Numerous studies have investigated vaccine-induced correlates of protection (CoP) against severe acute respiratory syndrome–coronavirus 2 (SARS–CoV-2) infection, but data on infection-induced CoP are limited.
Jianrong Shi   +9 more
doaj   +1 more source

Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity [PDF]

open access: yes, 2020
The world is currently witnessing an outbreak of a new coronavirus spreading quickly across China and affecting at least 24 other countries. With almost 65,000 infected, a worldwide death toll of at least 1370 (as of 14 February 2020), and with the ...
Dunker, A. Keith   +3 more
core   +1 more source

Prokaryotic Expression of the Influenza A (H5N1) Neuraminidase

open access: yesJournal of Mazandaran University of Medical Sciences, 2021
Background and purpose: Highly Pathogenic Influenza A(H5N1) viruses cause vast economic losses throughout the world. They may circulate in animals and be able to spread from human to human.
Zahra Latif   +3 more
doaj  

Geographical Distribution of Genetic Variants and Lineages of SARS-CoV-2 in Chile

open access: yesFrontiers in Public Health, 2020
The pandemic caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide public health concern. First confined in China and then disseminated widely across Europe and America, SARS-CoV-2 has impacted and moved the ...
Andrés E. Castillo   +11 more
doaj   +1 more source

A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine

open access: yesVirology Journal, 2021
Background Several studies on gamma-irradiated influenza A virus (γ-Flu) have revealed its superior efficacy for inducing homologous and heterologous virus-specific immunity.
Ailar Sabbaghi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy